<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>711</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15823604</PubmedId>
            <Abstract>The causative agent of severe acute respiratory syndrome (SARS) has been identified as a new type of coronavirus, SARS-associated coronavirus (SARS-CoV). CD8 T cells play an important role in controlling diseases caused by other coronaviruses and in mediating vaccine-induced protective immunity in corresponding animal models. The spike protein, a main surface antigen of SARS-CoV, is one of the most important antigen candidates for vaccine design. Overlapping peptides were used to identify major histocompatibility complex class I-restricted epitopes in mice immunized with vectors encoding codon-optimized SARS-CoV spike protein. CD8 T-cell responses were mapped to two H-2(b)-restricted epitopes (S436-443 and S525-532) and one H-2(d)-restricted epitope (S366-374). The identification of these epitopes will facilitate the evaluation of vaccine strategies in murine models of SARS-CoV infection. Furthermore, codon and promoter optimizations can greatly enhance the overall immunogenicity of spike protein in the context of replication-defective human and simian adenoviral vaccine carriers. The optimized recombinant adenoviral vaccine vectors encoding spike can generate robust antigen-specific cellular immunity in mice and may potentially be useful for control of SARS-CoV infection.</Abstract>
            <ArticleYear>2005</ArticleYear>
            <ArticlePages>34-45</ArticlePages>
            <ArticleTitle>Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Zhi</LastName>
                    <ForeName>Yan</ForeName>
                </Author>
                <Author>
                    <LastName>Kobinger</LastName>
                    <ForeName>Gary P</ForeName>
                </Author>
                <Author>
                    <LastName>Jordan</LastName>
                    <ForeName>Heather</ForeName>
                </Author>
                <Author>
                    <LastName>Suchma</LastName>
                    <ForeName>Katie</ForeName>
                </Author>
                <Author>
                    <LastName>Weiss</LastName>
                    <ForeName>Susan R</ForeName>
                </Author>
                <Author>
                    <LastName>Shen</LastName>
                    <ForeName>Hao</ForeName>
                </Author>
                <Author>
                    <LastName>Schumer</LastName>
                    <ForeName>Gregory</ForeName>
                </Author>
                <Author>
                    <LastName>Gao</LastName>
                    <ForeName>Guangping</ForeName>
                </Author>
                <Author>
                    <LastName>Boyer</LastName>
                    <ForeName>Julie L</ForeName>
                </Author>
                <Author>
                    <LastName>Crystal</LastName>
                    <ForeName>Ronald G</ForeName>
                </Author>
                <Author>
                    <LastName>Wilson</LastName>
                    <ForeName>James M</ForeName>
                </Author>
            </Authors>
            <Affiliations>Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, and The Wistar Institute, Philadelphia, PA 19104, USA.</Affiliations>
            <ArticleChemicalList>Codon;Epitopes, T-Lymphocyte;H-2 Antigens;Histocompatibility Antigen H-2D;Membrane Glycoproteins;Peptides;Spike Glycoprotein, Coronavirus;Viral Envelope Proteins;Viral Vaccines</ArticleChemicalList>
            <ArticleMeshHeadingsList>Adenoviruses, Human(genetics; immunology; metabolism); Amino Acid Sequence; Animals; CD8-Positive T-Lymphocytes(immunology); Cell Line; Chlorocebus aethiops; Codon; Epitope Mapping; Epitopes, T-Lymphocyte(immunology); Genetic Vectors(administration &amp; dosage; immunology); H-2 Antigens(metabolism); Histocompatibility Antigen H-2D; Humans; Immunization; Membrane Glycoproteins(genetics; immunology); Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Sequence Data; Peptides(chemistry; immunology); SARS Virus(immunology); Severe Acute Respiratory Syndrome(prevention &amp; control); Spike Glycoprotein, Coronavirus; Vero Cells; Viral Envelope Proteins(genetics; immunology); Viral Vaccines(administration &amp; dosage; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>335</Volume>
                <Issue>1</Issue>
                <Title>Virology</Title>
                <Issn>1096-0341</Issn>
                <MedlineTa>Virology</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YNYKYRYL</LinearSequence>
                        <StartingPosition>436</StartingPosition>
                        <EndingPosition>443</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P59594.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>227984</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>75237</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>7127</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P59594.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>227984</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose(s) of adenoviral vector encoding the source protein in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>YNYKYRYL</LinearSequence>
                                            <StartingPosition>436</StartingPosition>
                                            <EndingPosition>443</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P59594.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>227984</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Human adenovirus (replication-defective) encoding the SARS-CoV spike protein was used as a vector for immunization;  splenocytes were collected 8 or 10 days later.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellType>Unknown/Unspecified</CellType>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>122</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding prediction</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YNYKYRYL</LinearSequence>
                                        <StartingPosition>436</StartingPosition>
                                        <EndingPosition>443</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P59594.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>227984</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <AssayComments>The assay determined that more peptide used for stimulation results in a higher percentage of IFNg-stained cells.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VNFNFNGL</LinearSequence>
                        <StartingPosition>525</StartingPosition>
                        <EndingPosition>532</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P59594.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>227984</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>70066</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>7128</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P59594.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>227984</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose(s) of adenoviral vector encoding the source protein in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>VNFNFNGL</LinearSequence>
                                            <StartingPosition>525</StartingPosition>
                                            <EndingPosition>532</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P59594.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>227984</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Human adenovirus (replication-defective) encoding the SARS-CoV spike protein was used as a vector for immunization;  splenocytes were collected 8 or 10 days later.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellType>Unknown/Unspecified</CellType>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>167</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VNFNFNGL</LinearSequence>
                                        <StartingPosition>525</StartingPosition>
                                        <EndingPosition>532</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P59594.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>227984</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <AssayComments>The assay determined that more peptide used for stimulation results in a higher percentage of IFNg-stained cells.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CYGVSATKL</LinearSequence>
                        <StartingPosition>366</StartingPosition>
                        <EndingPosition>374</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P59594.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>227984</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 5</LocationOfData>
                <EpitopeId>7382</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 5 and 6</LocationOfData>
                        <TCellId>7129</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P59594.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>227984</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose(s) of adenoviral vector encoding the source protein in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CYGVSATKL</LinearSequence>
                                            <StartingPosition>366</StartingPosition>
                                            <EndingPosition>374</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P59594.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>227984</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Human adenovirus (replication-defective) encoding the SARS-CoV spike protein was used as a vector for immunization;  splenocytes were collected 8-days later.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellType>Unknown/Unspecified</CellType>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>169</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CYGVSATKL</LinearSequence>
                                        <StartingPosition>366</StartingPosition>
                                        <EndingPosition>374</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P59594.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>227984</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <AssayComments>The assay determined that more peptide used for stimulation results in a higher percentage of IFNg-stained cells.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 87</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TSTGNYNYKYRYLRH</LinearSequence>
                        <StartingPosition>431</StartingPosition>
                        <EndingPosition>445</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P59594.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>227984</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 7</LocationOfData>
                <EpitopeId>66460</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 7 and 8</LocationOfData>
                        <TCellId>7130</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P59594.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>227984</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose(s) of adenoviral vector encoding the source protein in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TSTGNYNYKYRYLRH</LinearSequence>
                                            <StartingPosition>431</StartingPosition>
                                            <EndingPosition>445</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P59594.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>227984</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Human adenovirus (replication-defective) encoding the SARS-CoV spike protein was used as a vector for immunization;  splenocytes were collected 8-days later.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellType>Unknown/Unspecified</CellType>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>Peptide 87</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TSTGNYNYKYRYLRH</LinearSequence>
                                        <StartingPosition>431</StartingPosition>
                                        <EndingPosition>445</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P59594.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>227984</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>61</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <AssayComments>The assay shows CD4 cells mobilized by the epitope. Different adenoviral vectors and promoters were compared for eliciting epitope specific T-cell responses. Combining the use of a simian adenovirus vector with a chicken beta-actin promoter gave a response comparable to using the human vector.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 88</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YNYKYRYLRHGKLRP</LinearSequence>
                        <StartingPosition>436</StartingPosition>
                        <EndingPosition>450</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P59594.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>227984</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 7</LocationOfData>
                <EpitopeId>75238</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <TCellId>7131</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P59594.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>227984</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose(s) of adenoviral vector encoding the source protein in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>YNYKYRYLRHGKLRP</LinearSequence>
                                            <StartingPosition>436</StartingPosition>
                                            <EndingPosition>450</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P59594.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>227984</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Human adenovirus (replication-defective) encoding the SARS-CoV spike protein was used as a vector for immunization;  splenocytes were collected 8-days later.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellType>Unknown/Unspecified</CellType>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>Peptide 88</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YNYKYRYLRHGKLRP</LinearSequence>
                                        <StartingPosition>436</StartingPosition>
                                        <EndingPosition>450</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P59594.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>227984</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>61</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <AssayComments>The assay shows CD4 cells  mobilized by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

